Culture Biosciences

Culture Biosciences develops automated bioreactor infrastructures and runs it as a service for biotech companies.

Year of Investment
2020
Investment Type
Series A
Investor
Jeff Fluhr
Bryan Rosenblatt
Category
B2B/SaaS
Exit